Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O HUGHES

Showing results (441-450 of 449) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 449 results.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Nature Protocols|May 6, 2021
Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health recordsNenad Tomašev, Natalie Harris, Sebastien Baur, et al.
Science (New York, N.Y.)|August 24, 2019
NAD<sup>+</sup> cleavage activity by animal and plant TIR domains in cell death pathwaysShane Horsefield, Hayden Burdett, Xiaoxiao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemRobert O Hughes, John K Walker, Jerry W Cubbage, et al.
Nature Medicine|August 15, 2018
Clinically applicable deep learning for diagnosis and referral in retinal diseaseJeffrey De Fauw, Joseph R Ledsam, Bernardino Romera-Paredes, et al.
Journal of Medicinal Chemistry|March 4, 2010
Design, synthesis, and biological evaluation of 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent, orally active, brain penetrant inhibitor of phosphodiesterase 5 (PDE5)Robert O Hughes, D Joseph Rogier, E Jon Jacobsen, et al.
Scientific Reports|November 20, 2025
Cross sections of [Formula: see text]Sm([Formula: see text]Li,x) reactions for the production of [Formula: see text]Tb for targeted alpha therapyLaura A Bills, Alan B McIntosh, Jonathan T Morrell, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsDafydd R Owen, John K Walker, E Jon Jacobsen, et al.
Pageof 45

Showing results (441-450 of 449) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 449 results.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Nature Protocols|May 6, 2021
Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health recordsNenad Tomašev, Natalie Harris, Sebastien Baur, et al.
Science (New York, N.Y.)|August 24, 2019
NAD<sup>+</sup> cleavage activity by animal and plant TIR domains in cell death pathwaysShane Horsefield, Hayden Burdett, Xiaoxiao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemRobert O Hughes, John K Walker, Jerry W Cubbage, et al.
Nature Medicine|August 15, 2018
Clinically applicable deep learning for diagnosis and referral in retinal diseaseJeffrey De Fauw, Joseph R Ledsam, Bernardino Romera-Paredes, et al.
Journal of Medicinal Chemistry|March 4, 2010
Design, synthesis, and biological evaluation of 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent, orally active, brain penetrant inhibitor of phosphodiesterase 5 (PDE5)Robert O Hughes, D Joseph Rogier, E Jon Jacobsen, et al.
Scientific Reports|November 20, 2025
Cross sections of [Formula: see text]Sm([Formula: see text]Li,x) reactions for the production of [Formula: see text]Tb for targeted alpha therapyLaura A Bills, Alan B McIntosh, Jonathan T Morrell, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsDafydd R Owen, John K Walker, E Jon Jacobsen, et al.
Pageof 45